25 fundings, $2B invested in NYC startups. No that’s not a typo. New York startups closed more in funding in the past week than the city of Miami has raised since 2019. NYC Tech News for the week ending 7/3 featuring news for Wellthy, Buzzer, and much, much more.
The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity in the various markets that we track. The notable startup funding rounds for the week ending 7/3/21 featuring funding details for ShipBob, LocoNav, Alto, and twenty-five other rounds that you need to know about.
Brands are set to spend $15B on influencer marketing by 2022. But at the end of the day, these creators that are powering the sales for the brands are beholden to third-parties in terms of platform and partners. In response, creator commerce is a growing subset of e-commerce where influencers, celebs, and content creators are directly transacting with their followers and fans, on owned channels. Pietra is an end-to-end platform that gives creators the infrastructure and tools to build and launch brands or product lines. Similar to a Shopify that’s built specifically for creators that haven’t explored commerce, the platform connects creators to vendors to source products, establishes warehousing and fulfillment, and builds owned web presences. Pietra even provides inventory financing options. The company is launching out of beta with over 20,000 users on the platform and this round comes at a $75M valuation.AlleyWatch caught up with CEO and Cofounder Ronak Trivedi to learn more about supporting the creator economy, the company’s future plans, and latest round of funding from investors that include Founders Fund, Andreessen Horowitz, Abstract Ventures, TQ Ventures, and Michael Ovitz.
$145M+ in new funding across 5 deals including 1 funding that you will not find anywhere else. The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 6/30/2021 featuring funding details for Buzzer, Novocardia, and much more.